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1. Introduction
   Diabetes mellitus is a group of metabolic disorders characterized 
by hyperglycemia. This metabolic disorder includes alteration in 
carbohydrate, fat and protein metabolism associated with absolute 
or relative deficiencies in insulin secretion and/or insulin action. The 
World Health Organization estimates that more than 347 million 
people worldwide have the disease. According to new estimates 
from the Centers for Disease Control and Prevention, about 26 
million Americans have diabetes. Currently, there is no cure for 
the disease. Millions of people all over the world have resorted to 
the use of medicinal plants for the management of the disease due 
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Objective: To evaluate the hypoglycemic and hypocholesterolemic activities of the aqueous 
preparation of Kalanchoe pinnata (K. pinnata) leaves in streptozotocin-induced diabetic rats. 
Methods: Diabetes mellitus was induced in rats by a single administration of streptozotocin 
(60 mg/Kg). Diabetic rats were then treated with aqueous K. pinnata for 30 d. Serum glucose, 
proteins, lipid composition, liver and kidney function indices, inflammatory markers, and key 
enzymes of hepatic carbohydrate and lipid metabolism were determined.
Results: The untreated and treated diabetic groups lost weight and consumed less food 
compared to the normal group. We noted 37.9% decrease in fasting blood glucose in the 
treated diabetic group compared to 13.2% and 17.0% increases in normal and untreated 
diabetic groups respectively. Serum cholesterol and triglyceride levels were significantly 
(P<0.05) reduced in the treated diabetic group compared to the untreated diabetic group. 
Blood urea nitrogen was significantly (P<0.05) elevated in the untreated and treated diabetic 
groups compared to the normal group. Serum alkaline phosphatase and hepatic pyruvate kinase 
activities were significantly (P<0.05) elevated in the treated diabetic group. Serum albumin 
level was significantly (P<0.05) reduced in the untreated diabetic group. Serum IL-6 was 
significantly (P<0.05) depressed in the treated diabetic group. 
Conclusions: The observed decrease in body weight, blood glucose and cholesterol level 
suggests that the aqueous K. pinnata preparation consumption may be beneficial in the 
management of diabetes mellitus. The observed adverse effect on alkaline phosphatase 
activity may be due to the combined effect of streptozotocin-induced diabetes and K. pinnata 
preparation administration. 
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to the rising cost of orthodox treatment and associated side effects. 
Most of these medicinal plants are used in developing countries 
for the treatment of diabetes, especially in the underprivileged 
populations. Since diabetes is a global disease, more than 800 
plants around the world have been identified as possible treatment 
options. Unfortunately, the use of many medicinal plant supplements 
in the management of diabetes and other diseases lack scientific 
backing. For example, doses and side effects of many medicinal 
plant preparations are not known. This makes herbal medicine a 
much riskier alternative to modern medicine. Kalanchoe pinnata 
(K. pinnata) is a medicinal plant found in South America, India, and 
the Caribbean. The plant has tall hollow stems, dark green scalloped 
leaves with red edges and produces dark bell-like pendulous flowers. 
The smaller reddish leaflets on the edges of the leaves are forming 
vegetative buds that are capable of producing individual plants on 
their own[1]. Aqueous preparations of plant leaves and roots are 
traditionally used for the treatment of a wide range of diseases in 
many parts of the world, including diabetes[2]. K. pinnata leaves 
have been reported to contain flavonoids, polyphenols, triterpenoids 
of β-amyrin structure, phytosterols etc[3,4]. The chemical constituents 
of the plant (flavonoids, polyphenols, triterpenoids and phytosterols) 
are speculated to account for the antinociceptive, antiinflammatory 
and antidiabetic activities of the herb’s leaf aqueous extract[5]. 
However, in this study, we evaluated the hypoglycemic and 
hypocholesterolemic activities of the aqueous preparation of K. 
pinnata in streptozotocin-induced diabetic rats.
2. Materials and methods
2.1. Aqueous preparation of K. pinnata
   A suitable weight of the plant leaves [the weight of the plant leaves 
was based on the weight of rats per cage to simulate the dose that is 
traditionally used in the management of diabetes (3 mature leaves 
~9.96 g/70 kg body weight or about 0.14 g/kg body weight)] was 
homogenized in deionized water daily. 
2.2. Induction of diabetes
   Two of three groups received a single injection of streptozotocin 
(Sigma-Aldrich Co., St. Louis, USA, 60 mg/kg body weight in 0.05 
mol/L citrate buffer, pH 4.5) intraperitoneally to induce diabetes. 
The third group (normal group) was injected intraperitoneally with 
an equivalent amount of buffer (0.05 mol/L citrate buffer, pH 4.5).
2.3. Experimental design
   Eighteen adult Sprague rats were assigned by weight into three 
groups for a 30 d study [6 rats per group, average body weight 
(297.28±15.17) g]. The groups were composed as follows: healthy 
rats receiving deionized water (normal group); diabetic control 
rats administered deionized water (diabetic group); diabetic rats 
administered aqueous preparation of K. pinnata orally (3 mature 
leaves ~9.96 g/70 kg body weight or about 0.14 g/kg body weight, 
traditionally used in the management of diabetes, treated diabetic 
group). Rats were housed in cages with solid flooring covered with 
a bedding material. The cages were cleaned daily. Approval for the 
study was obtained after review of the protocol by the Institutional 
Animal Care and Use Committee of the Institute of Biosciences 
and Technology, Texas A&M Health Sciences Center, Houston 
with protocol number 13 001. Diabetes was confirmed (with fasting 
blood glucose levels >240 mg/dL in the streptozotocin treated rats) 
by pricking the rat tail for a drop of blood for glucose determination 
after an overnight fast using a strip operated blood glucose meter 
(Bayer Contour Blood Glucose Monitoring System) on Day 8 
after streptozotocin injection. Rats in all groups were fed a normal 
rat diet. Body weight change and total food intake were recorded 
weekly. Animals were euthanized by decapitation on Day 30 after 
commencement of the feeding trial excluding the 8 d period for the 
development of the animal model of the disease which all the rats 
were administered deionized water. Blood and organ samples were 
collected for assays. 
2.4. Biochemical evaluation
   Serum glucose, lipid profile, total protein, albumin, uric acid and 
creatinine levels, alkaline phosphatase, alanine and aspartate amino 
transferase activities were measured using reagent kits for Sirrus 
Clinical Chemistry Analyzer from Stanbio Laboratory, Boerne, 
TX, USA. The levels of interleukin-1beta (IL-1β), interleukin 6 
(IL-6) and tumor necrosis factor alpha (TNF-α) in the serum were 
run in duplicate using commercial ELISA kits for rats (catalog 
numbers ER2IL1B, ER3IL6 and ER3TNFA respectively, according 
to the manufacturers’ instructions (Thermo Scientific/Pierce 
Biotechnology, Rockford, IL, USA) and Bio-Rad Microplate reader. 
The results are expressed in g/L. Liver samples were weighed and 
homogenized with suitable buffer [60 mmol/L sucrose, 220 mmol/
L mannitol, 10 mmol/L Tris-HCl (pH 7.4) containing 1 mmol/L 
ethylenediaminetetraacetic acid, 5 mmol/L dithiothreitol 1:10 w/
v]. Homogenates were centrifuged for 20 min at 5 708 r/min and 
the supernatant used as the source of metabolic enzymes. Metabolic 
enzyme activities in the liver were determined by measuring the 
change in extinction due to nicotinamide adenine dinucleotide 




   Results are presented as mean±SEM, n=6. ANOVA was used to 
test for differences among the groups. Post hoc analysis was carried 
out using the Duncan’s multiple range test to test for significant 
difference among the means (P<0.05).  
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3. Results
   Figure 1 shows body weight changes and food intake in diabetic 
rats administered aqueous preparation of K. pinnata. There was 
a decreasing trend in the average food intake among the groups 
(normal group>diabetic group>treated diabetic group). The treated 
diabetic group consumed less food compared to the other groups. 
While the normal group gained weight, the treated diabetic group 
lost more weight compared to the diabetic group. We noted a 
decrease (37.9%) in fasting blood glucose in the treated diabetic 
group compared to increases in normal (13.2%) and diabetic 
(17.0%) groups.
   Figure 2 shows serum lipid profile in diabetic rats administered 
aqueous preparation of K. pinnata. There was a significant (P<0.05) 
elevation in triglyceride level in the diabetic group, which was 
reduced towards normal level by the treatment. Total cholesterol 
level was also elevated in the diabetic group and there was a 
decreasing trend towards the normal group by the treatment. 
Additionally, high density lipoprotein (HDL) cholesterol was 
significantly (P<0.05) reduced in both diabetic and treated diabetic 
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Figure 1. Body weight changes and food intake in diabetic rats 
administered aqueous preparation of K. pinnata.































Diabetic Treated diabetic 
Figure 2. Serum lipid profile in diabetic rats administered aqueous 
preparation of  K. pinnata.
Figures that share different letter superscripts are significantly different 
(P<0.05).
   Figure 3 shows serum protein profile in diabetic rats administered 
aqueous preparation of K. pinnata. There was a significant (P<0.05) 
decrease in serum albumin level in the untreated diabetic group 
compared to the normal group. We observed increasing trend in 
albumin level in the treated diabetic group towards the normal 
group. The levels of total protein and globulin were not significantly 
altered among the groups. Similarly, albumin:globulin ratio was not 
significantly (P>0.05) altered among the groups (Figure 4).
   Figure 5 shows liver function enzymes in the serum of diabetic 
rats administered aqueous preparation of K. pinnata. Serum alanine 
amino transferase (ALT) and aspartate amino transferase (AST) 
activities were not significantly altered among the groups. However, 
there was a significant (P<0.05) increase in serum alkaline 
phosphatase (ALP) activity in the diabetic and diabetic treated 





























Diabetic Treated diabetic 
Figure 3. Serum protein profile in diabetic rats administered aqueous 
preparation of K. pinnata. 
Figures that share different letter superscripts are significantly different 
(P<0.05).
       Control                          Diabetic                    Treated diabetic 
Figure 4. Albumin:globulin ratio in diabetic rats administered aqueous 
preparation of K. pinnata.


















   Figure 6 shows metabolic enzyme activities in the liver of diabetic 
rats administered aqueous preparation of K. pinnata. Hepatic 
glucose-6-phosphate dehydrogenase (G6PD), malic enzyme and 
NADP+-isocitrate dehydrogenase activities were not significantly 
(P>0.05) altered among the groups. However, we noted a slight 
depression in hepatic G6PD activity in the treated diabetic group 
compared to the other groups. There was a significant (P<0.05) 
increase in pyruvate kinase activity in the treated diabetic group 
compared to the diabetic group.
   Table 1 shows kidney function parameters in the serum of rats 
administered aqueous preparation of K. pinnata. There was a 
significant (P<0.05) increase in blood urea nitrogen (BUN) in the 
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diabetic and treated diabetic groups compared to the normal group. 
However, serum creatinine and uric acid levels among the groups 
were not significantly (P>0.05) altered.
   Figure 7 shows serum interleukin levels in diabetic rats 
administered aqueous preparation of K. pinnata. We noted a 
significant (P<0.05) decrease in serum IL-6 levels in the treated 
diabetic group towards the normal group. There was a non-
significant elevation of serum TNF-α levels in the treated diabetic 
group compared to the diabetic group. IL-1β level was elevated in 
the diabetic and treated diabetic groups compared to the normal 
group.
Figure 5. Liver function enzymes in the serum of diabetic rats 
administered aqueous preparation of K. pinnata.






























Diabetic Treated diabetic 
Figure 6. Metabolic enzyme activities in the liver of diabetic rats 
administered aqueous preparation of K. pinnata.
Figures that share different letter superscripts are significantly different 
(P<0.05). G6PD: Glucose-6-phosphate dehydrogenase; ME: Malic 



































Diabetic Treated diabetic 
Table 1 
Kidney function parameters in diabetic rats administered aqueous 
preparation of K. pinnata.






Normal   91.48±24.32a 32.41±2.95a  7.56±0.27a
Diabetic   77.22±42.83a 26.52±3.95a 15.98±3.52b
Treated diabetic 112.86±59.40a 19.89±8.37a 20.17±3.08b
Values that share different letter superscripts vertically are significantly 
different (P<0.05).
Figure 7. Interleukin levels in the serum of diabetic rats administered 
aqueous preparation of K. pinnata.
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   The results of this laboratory animal study show that aqueous 
preparation of K. pinnata possesses anti-diabetic activities in 
streptozotocin-induced diabetic rats. There was a decreasing trend in 
the average food intake among the groups (normal group>diabetic 
group>treated diabetic group). The untreated and treated groups 
lost weight and consumed less food compared to the normal control 
group. However, the diabetic treated group’s loss in weight was 
more evident than the diabetic control group. Earlier study on 
blueberry extract with similar bioactive compounds also showed 
reduced food intake and body weight in rats due to its high satiating 
effects. However, the specific underlying mechanism was not 
presented[7]. It has also been reported that blueberries demonstrated 
antioxidant effects of reducing the accumulation of fat in aortas and 
livers of animal models, and reducing cardiovascular risk in obese 
individuals[8-11]. These biological effects are believed to be produced 
by phytosterols, phenolics and other bioactive compounds present 
in blueberries as K. pinnata aqueous preparation[5,12]. Since the 
leaves of K. pinnata are known to contain flavonoids, polyphenols, 
triterpenoids and phytosterols, it is generally believed that these 
chemical constituents might be responsible for the observed 
hypoglycemic activity of the herb[5]. Patterwar also reported that 
the plant could be beneficial in the management of diabetes because 
of the plant’s rich source of zinc[13]. An earlier report showed that 
pharmacological doses of zinc supplementation of animals and 
humans ameliorate glycemic control in diabetes[14]. Zinc is believed 
to exert insulin-like effects by supporting the signal transduction 
of insulin and by reducing the production of cytokines, which lead 
to beta-cell death during the inflammatory process in the pancreas 
disease[14]. The observed decrease in serum, total cholesterol 
level in the treated diabetic group may also be due to the chemical 
constituents of the K. pinnata preparation. For example, it has 
been suggested that the ability of phytosterols to lower serum total 
cholesterol is due to the similarity of their chemical structures. They 
displace intestinal cholesterol with bile salt micelles and compete for 
absorption from the border brush, thus by suppressing the absorption 
of dietary and biliary cholesterol and upregulation of the enterocyte 
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adenosine triphosphate-binding cassette transport proteins[15,16]. 
Similarly, Ho et al., showed that feeding 0.72% phytosterol-
containing milk powder lowered total cholesterol by 31% and low-
density lipoprotein-cholesterol by 52% in hypercholesterolemic 
hamsters[17]. Also, flavone, a class of flavonoids, has been reported 
to induce lipid lowering action in hyperlipidemic rats[18]. Gwon 
et al. suggested that flavones may be one of the candidates for 
an active component in Zanthoxylum piperitum extract as in K. 
pinnata aqueous preparation[19]. In their study, sterol regulatory 
element binding protein 1 was regulated by flavones, which led to 
down regulation of transcription factors and fatty acid synthase. 
They suggested that the inhibitory effect of Zanthoxylum piperitum 
extract on high fat diet-induced obesity may be partially attributed 
to flavones, which could also explain the decrease in body weight in 
our study. In addition, several systemic peptides have been shown to 
regulate appetite and body weight. We suggest further studies on the 
potential role of K. pinnata aqueous preparation on vital systemic 
peptides involved in the regulation of appetite and body weight. 
Previous studies of various natural extracts containing polyphenols 
were shown to decrease lipid accumulation and stimulate lipolysis 
in preadipocytes and adipocytes[20,21]. Elevated triglyceride level 
and reduced HDL levels are conducive to the development of 
atherosclerosis and increases the risk of cardiovascular disease[22]. 
In the diabetic state, there is a defect in the metabolism of stored 
triglycerides by adipose tissue resulting in elevated transport of 
free fatty acids to the liver, which triggers the overproduction of 
large very low-density lipoprotein fragments and triglycerides[23]. 
These result in secondary abnormalities of low HDL-cholesterol and 
increased low density lipoprotein (LDL)[24]. Elevated level of LDL 
cholesterol is subject to oxidative modification and transformation 
into foam cells, which accumulate in the form of fatty streaks and 
fibrofatty plaques that lead to the development of atherosclerosis[23]. 
Although the treatment was able to decrease the triglyceride level 
which may reduce cardiovascular risk, and the non-restoration of 
HDL-cholesterol level towards the normal control group may be 
a drawback in the use of the preparation for the management of 
diabetes. However, the evaluation of the entire lipid profile which 
includes LDL, very low-density lipoprotein and lipid moieties are 
required to ascertain whether the tissues are taking up excess lipids 
or improving fuel utilization. The liver is the main site of synthesis 
of plasma proteins, especially albumin. Changes in serum total 
proteins or the ratio of albumin and globulin may be indicative of 
hepatic dysfunction. These changes in plasma proteins usually do 
not appear except in chronic or severe liver dysfunction that may 
be evidenced by a decrease in albumin and an increase in globulin 
concentration. The untreated diabetic group showed a significant 
decrease in the albumin level comparable to the normal control 
group. However, there was an increasing trend in the albumin level 
in the diabetic treated towards the normal control group. The liver 
enzymes, ALT, AST and ALP are cellular enzymes that are present 
in low concentrations in serum under normal conditions. Significant 
increases in serum concentrations result from either increased 
synthesis of the enzyme or increased rate of leakage from damaged 
cells[25]. Serum ALT and AST levels are clinically and toxicologically 
important indicators of tissue damage caused by toxicants or disease 
conditions[26]. Changes in detectable liver enzyme activity before 
physical symptoms of tissue damage are usually apparent. Our 
data on serum proteins and liver function enzymes showed that the 
consumption of K. pinnata preparation may protect against liver 
damage associated with diabetes mellitus. Although the observed 
increase in serum alkaline phosphatase activity may be indicative 
of tissue damage in the diabetic treated group. However, it can be 
highly nonspecific in terms of organ function. Further studies are 
needed on the effect of the treatment on alkaline phosphatase activity 
in diabetes mellitus.
   One of the regulatory reactions of glycolysis is catalyzed by 
pyruvate kinase, while one key reaction of the pentose phosphate 
pathways is catalyzed by G6PD. This latter reaction generates 
reduced nicotinamide adenine dinucleotide phosphate (NADPH) 
for the synthesis of steroids and fatty acids. Malic enzyme and 
NADP-ISD similarly generate NADPH for reductive biosynthesis. 
The observed significant (P<0.05) increase in pyruvate kinase 
activity in the treated diabetic group may suggest heightened 
glucose metabolism due to consumption of the aqueous K. pinnata 
preparation which may account for the hypoglycemic activity. The 
slight depression in hepatic G6PD activity in the treated diabetic 
group may be indicative of a depressed pentose phosphate pathway. 
This pathway generates NADPH for the synthesis of steroids and fatty 
acids, and could partly explain the observed hypocholesterolemic 
activity of K. pinnata preparation consumption in diabetes mellitus.  
   The observed significant (P<0.05) increase of BUN in the diabetic 
and diabetic treated groups compared to the control group may be 
indicative of renal insufficiency or dehydration and this is usually 
coupled with an increase in creatinine level, but this was not the 
case in this study. Both BUN and creatinine are valuable screening 
tests in evaluating renal disease. However, creatinine is a more 
reliable indicator of renal function than BUN because BUN is more 
likely to be affected by dietary and physiologic conditions that are 
not related to renal function.
   Systemic IL-1β, TNF-α, and IL-6 levels have been found to be 
elevated during aging and diabetes[27]. Proinflammatory cytokines 
such as TNF-α and IL-1β also participate in the pathogenesis of 
atherosclerosis by inducing E-selectin, intercellular adhesion 
molecule 1 and vascular cell adhesion molecule 1 expression in 
endothelial cells[28]. Kong et al. reported that IL-1β and TNF-α 
are two important proinflammatory cytokines in the initiation and 
development of atherosclerosis[29]. The elevated levels of these 
interleukins (IL-1β and TNF-α) in our study suggest that the use of 
K. pinnata preparation in the management of diabetes mellitus may 
not be effective in ameliorating the potential for the development 
of atherosclerosis. Our data show that another proinflammatory 
cytokine (IL-6) that is up-regulated in diabetes was significantly 
depressed by the administration of aqueous preparation. The level of 
IL-6 has been shown to be elevated during the acute phase response, 
which could be triggered by diabetes and subsequently lead to 
the release of effector molecules that might cause endothelial 
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dysfunction leading to atherosclerosis[30,31]. We hypothesize that 
the observed significant down-regulation of IL-6 in the treated 
diabetic group ameliorates the adverse effects associated with 
the up-regulation of IL-1β and TNF-α, which may account for 
our observation that K. pinnata preparation may protect against 
cardiovascular risk associated with diabetes mellitus.
   Overall, the aqueous preparation of K. pinnata demonstrated a 
decrease in body weight, and hypoglycemic and hypocholesterolemic 
activities which are beneficial in the management of diabetes. The 
decrease in blood glucose may be due to the increased glycolytic 
pathway in the liver as shown by the elevated pyruvate kinase 
activity. While the elevation of BUN could be a cause for concern, 
it is not the most sensitive indicator of renal damage and could be 
elevated due to a number of unrelated factors. The inflammatory 
cytokine (IL-6) normally up-regulated in diabetes was significantly 
depressed by the aqueous preparation. Although the consumption of 
the aqueous preparation of K. pinnata may accrue some benefits in 
the management of diabetes, further studies are needed to evaluate 
the long-term effects of K. pinnata preparation versus a positive 
control drug currently used in the treatment of diabetes mellitus 
on serum ALP activity and BUN level in streptozotocin-induced 
diabetes.
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Comments 
Background
   This is an animal study on the pathogenesis of diabetes mellitus. 
It is a kind of ethnopharmacology of a locally available species in 
Africa. The work can be a good data for further study. 
  
Research frontiers
   This is a good animal model study on a tropical species that can be 
applicable used as a local wisdom regimen against diabetes mellitus. 
The information is new and interesting. Also, the result can be useful 
in diabetology in the future. 
Related reports
   There are some related reports but not on this specific studied 
species. The work remains its originality and has new data. 
Innovations and breakthroughs
   This work can be further applied in the future biomedical study on 
this tropically available species. The work represents a good example 




   The work can be good basic information for further diabetology 
research. Also, the study represents good ethnopharmacology that 
can be further referenced in the related field.       
Peer review
   The report on animal model study with diabetes mellitus and the 
test regimen is on a local tropical species from Africa. The work is 
a good and standard study on ethnopharmacology. New information 
can be derived and this is useful for further drug research and 
development. In addition, the information from this work can add up 
the database on pharmacology, ethnopharmacology and diabetology. 
Further citation can be expected. 
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